“… already been the subject of contested proceedings in the UK courts. This court considered that question in Neurim Pharmaceuticals (1991) Ltd v Generics UK Ltd [2022] EWCA Civ 359. The simplified facts were as follows. Neurim was the proprietor of a European patent, granted in 2017, concerning the use of prolonged-release melatonin, for …”
“… unnecessary for this Court to consider the issue identified in my judgment on the Claimants’ appeal against two aspects of the judge’s order concerning EP702: [2022] EWCA Civ 359 at [55].…”
“… in the European Patent Office concerning EP702 is summarised in my judgment on an appeal in the First Claim heard immediately before the hearing in this claim [2022] EWCA Civ 359 at [30]-[38]. For present purposes the key events are as follows.…”